Health Affairs

• 

  Publication Venue For

  • Financial Impacts And Operational Implications Of Private Equity Acquisition Of US Hospitals..  41:523-530. 2022
  • Improving The Measurement Of Structural Racism To Achieve Antiracist Health Policy..  41:179-186. 2022
  • Sick And Tired Of Being Excluded: Structural Racism In Disenfranchisement As A Threat To Population Health Equity..  41:219-227. 2022
  • Increasing Insurance Choices In The Affordable Care Act Marketplaces, 2018-21..  40:1706-1712. 2021
  • Private Equity Acquisition And Responsiveness To Service-Line Profitability At Short-Term Acute Care Hospitals..  40:1697-1705. 2021
  • Association Of Unemployment With Medicaid Enrollment By Social Vulnerability In North Carolina During COVID-19..  40:1491-1500. 2021
  • ​US Tropical Disease Priority Review Vouchers: Lessons In Promoting Drug Development And Access..  40:1243-1251. 2021
  • Private Equity Investments In Health Care: An Overview Of Hospital And Health System Leveraged Buyouts, 2003-17..  40:719-726. 2021
  • Paying For Value From Costly Medical Technologies: A Framework For Applying Value-Based Payment Reforms..  39:1018-1025. 2020
  • Terminating Cost-Sharing Reduction Subsidy Payments: The Impact Of Marketplace Zero-Dollar Premium Plans On Enrollment..  39:41-49. 2020
  • Rural-Urban Differences In Individual-Market Health Plan Affordability After Subsidy Payment Cuts..  38:2032-2040. 2019
  • Why Do Accountable Care Organizations Leave The Medicare Shared Savings Program?.  38:794-803. 2019
  • Machine-Based Expert Recommendations And Insurance Choices Among Medicare Part D Enrollees..  38:482-490. 2019
  • Seven Former FDA Commissioners: The FDA Should Be An Independent Federal Agency..  38:84-86. 2019
  • Insurer Market Concentration..  37:1712. 2018
  • Physicians Are People, TooAlso Human: The Inner Lives Of Doctors By Caroline Elton New York (NY): Basic Books, 2018 336 pp., $30.00.  37:1337-1338. 2018
  • Marketplace Plans Provide Risk Protection, But Actuarial Values Overstate Realized Coverage For Most Enrollees..  36:2078-2084. 2017
  • Accountable Care Reforms Improve Women's And Children's Health In Nepal..  36:1965-1972. 2017
  • Global Lessons In Frugal Innovation To Improve Health Care Delivery In The United States..  36:1912-1919. 2017
  • Improving Care And Lowering Costs: Evidence And Lessons From A Global Analysis Of Accountable Care Reforms..  36:1920-1927. 2017
  • Mortality In Rural China Declined As Health Insurance Coverage Increased, But No Evidence The Two Are Linked..  36:1672-1678. 2017
  • A Voucher System To Speed Review Could Promote A New Generation Of Insecticides To Fight Vector-Borne Diseases..  36:1461-1468. 2017
  • A Positive Association Between Hospice Profit Margin And The Rate At Which Patients Are Discharged Before Death..  36:1291-1298. 2017
  • Bridging The Death GapThe Death Gap: How Inequality Kills By Ansell David A. Chicago (IL) : University of Chicago Press , 2017 240 pp., $26.00.  36:1140-1140. 2017
  • Strategies For Assessing Delivery System Innovations..  36:408-416. 2017
  • Effect Of A Large-Scale Social Franchising And Telemedicine Program On Childhood Diarrhea And Pneumonia Outcomes In India..  35:1800-1809. 2016
  • Quality Of Health Care In India: Challenges, Priorities, And The Road Ahead..  35:1753-1758. 2016
  • Trends In State-Level Child Mortality, Maternal Mortality, And Fertility Rates In India..  35:1759-1763. 2016
  • Medicare Advantage Plans Pay Hospitals Less Than Traditional Medicare Pays..  35:1444-1451. 2016
  • The Commercial Market For Priority Review Vouchers..  35:776-783. 2016
  • No Shot: US Vaccine Prices And Shortages..  35:235-241. 2016
  • Consumption Of Specific Foods And Beverages And Excess Weight Gain Among Children And Adolescents..  34:1940-1948. 2015
  • Innovations In Diabetes Care Around the World: Case Studies Of Care Transformation Through Accountable Care Reforms..  34:1489-1497. 2015
  • Treating Age-Related Macular Degeneration: Comparing The Use Of Two Drugs Among Medicare And Veterans Affairs Populations (vol 34, pg 229, 2015).  34:717-717. 2015
  • Creating value in health by understanding and overcoming resistance to de-innovation..  34:239-244. 2015
  • Improving pharmaceutical innovation by building a more comprehensive database on drug development and use..  34:319-327. 2015
  • Repairing the broken market for antibiotic innovation..  34:277-285. 2015
  • The roles of patents and research and development incentives in biopharmaceutical innovation..  34:302-310. 2015
  • Treating age-related macular degeneration: comparing the use of two drugs among medicare and veterans affairs populations..  34:229-238. 2015
  • An economic framework for preventive care advice..  33:2034-2040. 2014
  • Accountable care around the world: a framework to guide reform strategies..  33:1507-1515. 2014
  • Patients' preferences explain a small but significant share of regional variation in medicare spending..  33:957-963. 2014
  • Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future..  33:1048-1057. 2014
  • High incarceration rates among black men enrolled in clinical studies may compromise ability to identify disparities..  33:848-855. 2014
  • Vertical integration: hospital ownership of physician practices is associated with higher prices and spending..  33:756-763. 2014
  • Private insurers' payments for routine physician office visits vary substantially across the United States..  32:1583-1590. 2013
  • Evolving Reimbursement And Pricing Policies For Devices In Europe And The United States Should Encourage Greater Value.  32:788-796. 2013
  • Unintended consequences of steps to cut readmissions and reform payment may threaten care of vulnerable older adults..  31:1623-1632. 2012
  • In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survival..  31:709-717. 2012
  • Inviting consumers to downsize fast-food portions significantly reduces calorie consumption..  31:399-407. 2012
  • Nurses for patient-centered medical homes.  31:2593-. 2012
  • Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act..  30:2157-2166. 2011
  • Measuring health care performance now, not tomorrow: essential steps to support effective health reform..  30:682-689. 2011
  • Controversy undermines support for state mandates on the human papillomavirus vaccine..  29:2041-2046. 2010
  • HMO coverage reduces variations in the use of health care among patients under age sixty-five..  29:2068-2074. 2010
  • An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps..  29:1768-1776. 2010
  • Beyond the Affordable Care Act: achieving real improvements in Americans' health..  29:1481-1488. 2010
  • A national strategy to put accountable care into practice..  29:982-990. 2010
  • Personal responsibility and obesity: a constructive approach to a controversial issue..  29:379-387. 2010
  • Predicting support for restricting food marketing to youth..  29:419-424. 2010
  • Cancer therapy costs influence treatment: a national survey of oncologists..  29:196-202. 2010
  • Health Care Cost Growth Among The Privately Insured (vol 28, pg 1294, 2009).  29:223-223. 2010
  • Annual medical spending attributable to obesity: payer-and service-specific estimates..  28:w822-w831. 2009
  • Health care cost growth among the privately insured..  28:1294-1304. 2009
  • Fostering accountable health care: moving forward in medicare..  28:w219-w231. 2009
  • Colorectal cancer screening: prevalence among low-income groups with health insurance..  28:169-177. 2009
  • Availability and prices of foods across stores and neighborhoods: the case of New Haven, Connecticut..  27:1381-1388. 2008
  • Would greater transparency and uniformity of health care prices benefit poor patients?.  26:1384-1391. 2007
  • The quantity and quality of worldwide new drug introductions, 1982-2003..  25:452-460. 2006
  • Postapproval drug safety: The authors respond.  25:1187-1188. 2006
  • Postapproval drug safety: The authors respond [8].  25:1187-1188. 2006
  • Functional gaps in attaining a national health information network..  24:1281-1289. 2005
  • The making and adoption of health data standards..  24:1205-1213. 2005
  • What about physician assistants?.  24:886-887. 2005
  • Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator..  24:42-51. 2005
  • States' allocations of funds from the tobacco master settlement agreement..  24:220-227. 2005
  • Overcoming barriers to adopting and implementing computerized physician order entry systems in U.S. hospitals..  23:184-190. 2004
  • The general agreement on trade in services: implications for health policymakers..  23:137-145. 2004
  • Does competition for transplantable hearts encourage 'gaming' of the waiting list?.  23:191-198. 2004
  • Better health, lower spending..  23:273-274. 2004
  • Defining the balance of risk and benefit in the era of genomics and proteomics..  23:77-87. 2004
  • The role of standards in electronic prescribing..  Suppl Web Exclusives:W4-325-7. 2004
  • The role of standards in electronic prescribing..  Suppl Web Exclusives. 2004
  • Mandated treatment in the community for people with mental disorders..  22:28-38. 2003
  • National medical spending attributable to overweight and obesity: how much, and who's paying?.  Suppl Web Exclusives:W3-219-26. 2003
  • Pharmacogenetic challenges for the health care system..  21:155-167. 2002
  • How Disclosing HMO Physician Incentives Affects Trust.  21:197-206. 2002
  • The economics of alcohol abuse and alcohol-control policies..  21:120-133. 2002
  • Gauging supply and demand: the challenging quest to predict the future physician workforce..  21:167-168. 2002
  • Providing care at the end of life: do Medicare rules impede good care?.  20:204-211. 2001
  • Does economic theory justify changing policy that works?.  20:153-155. 2001
  • Pennsylvania's voluntary benefits program: evaluating an innovative proposal for increasing organ donation..  19:206-211. 2000
  • Managed behavioral health care: a Medicaid carve-out for youth..  18:214-225. 1999
  • Children's mental health service use across service sectors..  14:147-159. 1995
  • Nursing home reform and the mentally ill..  9:47-60. 1990
  • The cultural dimensions of alcohol policy worldwide..  8:48-62. 1989
  • Shifting Medicare patients out of the hospital..  7:52-64. 1988
  • Rising rates of surgery among the elderly..  4:108-119. 1985
  • Investor-owned and not-for-profit hospitals: Addressing some issues.  2:25-37. 1983
  • State rate setting: an analysis of some unresolved issues..  2:36-47. 1983
  • Health Equity Should Be A Key Value In Value-Based Payment And Delivery Reform 2020
  • Leveraging Payment Reforms For COVID-19 And Beyond: Recommendations For Medicare ACOs And CMS’s Interim Final Rule 2020